Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (51-60 of 10,652) with videos related to

Pageof 1,066
Sort By:
Current Pharmaceutical Design|June 17, 2010
Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic riskAmalia Gastaldelli, Franco Folli, Silvia Maffei
Current Pharmaceutical Design|July 17, 2010
Treatment of Takotsubo cardiomyopathyTomas Palecek, Petr Kuchynka, Ales Linhart
Current Pharmaceutical Design|August 7, 2010
Peptidomimetic competitive inhibitors of protein tyrosine phosphatasesKui Shen, Lixin Qi, Lynn Stiff
Current Pharmaceutical Design|August 7, 2010
Epitope discovery and their use in peptide based vaccinesNadine L Dudek, Patrick Perlmutter, Marie-Isabel Aguilar, et al.
Current Pharmaceutical Design|August 7, 2010
Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from viperidae snake venoms: biomimetic activities and potential applicationsBruno Lomonte, Yamileth Angulo, Edgardo Moreno
Current Pharmaceutical Design|August 7, 2010
Peptides targeting gap junctional structuresJean-Claude Hervé, Stefan Dhein
Current Pharmaceutical Design|August 7, 2010
Orexins/hypocretins: pain regulation and cellular actionsLih-Chu Chiou, Hsin-Jung Lee, Yu-Cheng Ho, et al.
Current Pharmaceutical Design|August 7, 2010
Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulationEoin R Feeney, Patrick W G Mallon
Current Pharmaceutical Design|October 15, 2010
A review of the chemical and pharmacological aspects of the genus marrubiumChristiane Meyre-Silva, Valdir Cechinel-Filho
Current Pharmaceutical Design|January 20, 2009
Nicotinamide adenine dinucleotide biology and diseaseW Todd Penberthy
Pageof 1,066

Showing results (51-60 of 10,652) with videos related to

Sort By:
Pageof 1,066
Current Pharmaceutical Design|June 17, 2010
Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic riskAmalia Gastaldelli, Franco Folli, Silvia Maffei
Current Pharmaceutical Design|July 17, 2010
Treatment of Takotsubo cardiomyopathyTomas Palecek, Petr Kuchynka, Ales Linhart
Current Pharmaceutical Design|August 7, 2010
Peptidomimetic competitive inhibitors of protein tyrosine phosphatasesKui Shen, Lixin Qi, Lynn Stiff
Current Pharmaceutical Design|August 7, 2010
Epitope discovery and their use in peptide based vaccinesNadine L Dudek, Patrick Perlmutter, Marie-Isabel Aguilar, et al.
Current Pharmaceutical Design|August 7, 2010
Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from viperidae snake venoms: biomimetic activities and potential applicationsBruno Lomonte, Yamileth Angulo, Edgardo Moreno
Current Pharmaceutical Design|August 7, 2010
Peptides targeting gap junctional structuresJean-Claude Hervé, Stefan Dhein
Current Pharmaceutical Design|August 7, 2010
Orexins/hypocretins: pain regulation and cellular actionsLih-Chu Chiou, Hsin-Jung Lee, Yu-Cheng Ho, et al.
Current Pharmaceutical Design|August 7, 2010
Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulationEoin R Feeney, Patrick W G Mallon
Current Pharmaceutical Design|October 15, 2010
A review of the chemical and pharmacological aspects of the genus marrubiumChristiane Meyre-Silva, Valdir Cechinel-Filho
Current Pharmaceutical Design|January 20, 2009
Nicotinamide adenine dinucleotide biology and diseaseW Todd Penberthy
Pageof 1,066